Trademarkia Logo

Australia

AU$
INHERIS
Cancelled: Cancelled at the request of IB

Last updated on 12 Jul 2021

Owner Info

Inheris Pharmaceuticals, Inc.

150 North Riverside Plaza, Suite 1840

Chicago IL 60606, UNITED STATES OF AMERICA

Serial Number

2027129 filed on 17 Jun 2019

Correspondent

Kilpatrick Townsend & Stockton LLP

Mailstop: IP Docketing - 22,,

1100 Peachtree Street, Suite 2800,

UNITED STATES OF AMERICA

INHERIS

Classification Information


Class [005]
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophy Read More

Class [042]
Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields.

Mark Details


Serial Number

2027129

Registered On

17 Jun 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

18 Dec 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Jul 2021Status change to Voided
29th Jan 2020International Registration in Australia Protected correspondence sent
28th Jan 2020IP Right Registration Published
28th Jan 2020Status change to Registered/Protected
20th Jan 2020Owner name details updated
16th Jan 2020Owner name details updated
9th Jan 2020Amendment to Amend Owner Requested
9th Jan 2020Full Assignment Requested
19th Nov 2019Application Accepted correspondence sent
18th Nov 2019IP Right Acceptance Published